BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 28179656)

  • 21. Immune Cells and Metabolism.
    Chatzigeorgiou A; Chavakis T
    Handb Exp Pharmacol; 2016; 233():221-49. PubMed ID: 25903417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional repression in macrophages-basic mechanisms and alterations in metabolic inflammatory diseases.
    Treuter E; Fan R; Huang Z; Jakobsson T; Venteclef N
    FEBS Lett; 2017 Oct; 591(19):2959-2977. PubMed ID: 28902388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation.
    Laugerette F; Vors C; Peretti N; Michalski MC
    Biochimie; 2011 Jan; 93(1):39-45. PubMed ID: 20433893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The true cost of in-patient obesity: impact of obesity on inflammatory stress and morbidity.
    Grimble RF
    Proc Nutr Soc; 2010 Nov; 69(4):511-7. PubMed ID: 20598196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells, leptin and angiogenesis.
    Pucino V; De Rosa V; Procaccini C; Matarese G
    Chem Immunol Allergy; 2014; 99():155-69. PubMed ID: 24217608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte roles in metabolic dysfunction: of men and mice.
    Ip BC; Hogan AE; Nikolajczyk BS
    Trends Endocrinol Metab; 2015 Feb; 26(2):91-100. PubMed ID: 25573740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Nlrp3 inflammasome by dietary metabolites.
    Camell C; Goldberg E; Dixit VD
    Semin Immunol; 2015 Sep; 27(5):334-42. PubMed ID: 26776831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement in metabolic disease: metaflammation and a two-edged sword.
    King BC; Blom AM
    Semin Immunopathol; 2021 Dec; 43(6):829-841. PubMed ID: 34159399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic inflammation and the central nervous system control of energy homeostasis.
    Pimentel GD; Ganeshan K; Carvalheira JB
    Mol Cell Endocrinol; 2014 Nov; 397(1-2):15-22. PubMed ID: 24952114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation.
    Flock MR; Rogers CJ; Prabhu KS; Kris-Etherton PM
    Diabetes Metab Res Rev; 2013 Sep; 29(6):431-45. PubMed ID: 23592441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammaging: a new immune-metabolic viewpoint for age-related diseases.
    Franceschi C; Garagnani P; Parini P; Giuliani C; Santoro A
    Nat Rev Endocrinol; 2018 Oct; 14(10):576-590. PubMed ID: 30046148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation.
    Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E
    Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental Origins of Metaflammation; A Bridge to the Future Between the DOHaD Theory and Evolutionary Biology.
    Itoh H; Ueda M; Suzuki M; Kohmura-Kobayashi Y
    Front Endocrinol (Lausanne); 2022; 13():839436. PubMed ID: 35185805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.
    Ferrante AW
    J Intern Med; 2007 Oct; 262(4):408-14. PubMed ID: 17875176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosome/lipid droplet interplay in metabolic diseases.
    Dugail I
    Biochimie; 2014 Jan; 96():102-5. PubMed ID: 23880642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside.
    Zhang Y; Tan S; Xu J; Wang T
    Cell Physiol Biochem; 2018; 47(1):1-10. PubMed ID: 29763888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mineralocorticoid receptor: a new player controlling energy homeostasis.
    Kuhn E; Lombès M
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):59-69. PubMed ID: 25436733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver.
    Dimova EY; Kietzmann T
    Thromb Haemost; 2008 Dec; 100(6):992-1006. PubMed ID: 19132222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.